Biodexa Pharmaceuticals (BDRX) Research & Development (2013 - 2025)

Biodexa Pharmaceuticals (BDRX) posted Research & Development of -$2.2 million for Q2 2025, up 20.94% sequentially from -$2.8 million in Q4 2024.

Biodexa Pharmaceuticals (BDRX) Research & Development (2013 - 2025) Analysis & Trends

Biodexa Pharmaceuticals has reported Research & Development for 12 years, with the latest figure at -$2.2 million in Q2 2025.

Quarterly Research & Development changed N/A year-over-year to -$2.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$10.7 million (changed N/A YoY) and the FY2025 annual result came in at -$5.2 million, up 25.16% from the prior year.
Research & Development climbed to -$2.2 million in Q2 2025 per BDRX's latest filing, from -$2.8 million in the prior quarter.
Over five years, Research & Development peaked at -$2.2 million in Q2 2025 and troughed at -$3.0 million in Q3 2022.
A 5-year average of -$2.7 million and a median of -$2.8 million in 2024 frame the typical range for Research & Development.
The sharpest annual moves came in 2021 and 2022: Research & Development jumped 66.18% in 2021, then fell 6.85% in 2022.
Over 5 years, Research & Development stood at -$2.7 million in 2021, then decreased by 4.46% to -$2.8 million in 2022, then gained by 0.48% to -$2.8 million in 2023, then increased by 0.26% to -$2.8 million in 2024, then climbed by 20.94% to -$2.2 million in 2025.
According to Business Quant data, Research & Development over the past three periods registered -$2.2 million, -$2.8 million, and -$2.8 million for Q2 2025, Q4 2024, and Q2 2023 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	R&D (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	993.80 Mn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	1.63 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	651.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	612.28 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	413.13 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	210.03 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	97.90 Mn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	-588.31 Mn
10	Biodexa Pharmaceuticals	63,168.17	-11.29 Mn	-	-

Download Data